Our technology enables you to check the antigenicity (efficacy) and safety of your inactivated viral vaccine in vitro
A quick and safe way to develop safe and effective viral vaccines against emerging diseases or new aggressive strains
Fully documented proof-of-concept study on a PRRSV-vaccine, that is capable of inducing neutralizing antibodies upon vaccination and protection upon challenge with live virus
Complete toolkit for the production of an inactivated PRRSV-vaccine including
Antibodies to check structural integrity of critical viral proteins
Diagnostics to check the antigenicity of the inactivated virus
Please download the Technology Offer for more information.